protooncogenes
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
11.02.2019
TEOXANE Wins Award for Best Injectable Treatment at 2018 Aesthetics Awards
TEOXANE Laboratories is proud to announce that its Hyaluronic acid dermal filler, TEOSYAL®RHA, has been recognised at the prestigious Aesthetics Awards as the leading injectable treatment of 2018. The much […]
12.05.2020
The CE certified needle roller of the NETWORK Aesthetics
The network’s new needle roller, called SPEEDY, is one of the few products in this market segment that has received a medical CE to date. We warn against dubious suppliers who offer their products cheaply via Internet platforms (e.g. Amazon, Alibaba ).